RAPT (RAPT Therapeutics, Inc.) חוב לטווח קצר להון

RAPT Therapeutics, Inc. (RAPT) is a biotechnology player in the immunology sector facing clinical trial uncertainty and a shortage of R&D funding. This daily price chart confirms these challenges, where the metric stands at 0.02. The company develops safe oral agents to combat tumors through targeted cellular action. The brand is currently restoring physician confidence following the temporary suspension of several studies.

For the biotechnology sector, the RAPT Therapeutics, Inc. (RAPT) chart of short-term loans to equity serves as a liquidity indicator amid an investment deficit. This metric compares the volume of liabilities with a maturity of over one year against the amount of shareholder equity. This ratio determines the company's dependence on external financing as cash reserves are depleted. An increase in this indicator against the backdrop of halted drug trials signals a critical weakening of financial stability.